Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 38, 4486-4495, December 1, 1978]
© 1978 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Erratum (v39,p3287)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benson, A. M.
Right arrow Articles by Talalay, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benson, A. M.
Right arrow Articles by Talalay, P.

Elevation of Hepatic Glutathione S-Transferase Activities and Protection against Mutagenic Metabolites of Benzo(a)pyrene by Dietary Antioxidants1

Ann M. Benson, Robert P. Batzinger, Suh-Yun L. Ou, Ernest Bueding, Young-Nam Cha and Paul Talalay2

Department of Pharmacology and Experimental Therapeutics, The Johns Hopkins University School of Medicine [A. M. B., E. B., P. T.], and Department of Pathobiology, The Johns Hopkins University School of Hygiene and Public Health [R. P. B., S-Y. L. O., E. B., Y-N. C.], Baltimore, Maryland 21205

Addition of either 2(3)-tert-butyl-4-hydroxyanisole (BHA) or 1,2-dihydro-6-ethoxy-2,2,4-trimethylquinoline (ethoxyquin) to the diet greatly decreases the levels of mutagenic metabolites of benzo(a)pyrene in CD-1 mice. (R. P. Batzinger, S-Y. L. Ou, and E. Bueding, Cancer Res., 38:000, 1978). The mutagenic activity of the urinary metabolites of benzo(a)pyrene is markedly reduced in the presence of glutathione together with the liver cytosols of rats or mice fed on a diet containing BHA. The liver cytosols of mice and rats maintained on control diets are much less effective in this respect. Dietary BHA causes increases in mouse and rat hepatic glutathione S-transferase (EC 2.5.1.18) specific activities with 1,2-dichloro-4-nitrobenzene, 1-chloro-2,4-dinitrobenzene, p-nitrobenzylchloride, and {Delta}5-androstene-3,17-dione. In the mouse the increases are larger (5- to 10-fold) and are dependent on the dose and duration of administration of BHA. Increases in these glutathione S-transferase specific activities were also observed in mouse hepatic cytosols after feeding of ethoxyquin. Direct addition of reduced glutathione and purified glutathione S-transferases A and B obtained from rat liver to the mutagenicity assay system mimicked the effect of the rodent cytosols. Since BHA and ethoxyquin are known to reduce the neoplastic effects of a variety of potent carcinogens, we suggest that the protective effects of these antioxidants may be accounted for, at least in part, by their ability to elevate the glutathione S-transferases. These enzymes inactivate arene oxides and other hydrophobic electrophiles by catalyzing their conjugation with glutathione.

1 Supported by NIH Grants GM 16492, AI 08022, AM 07422, and CA 18251 and by the Edna McConnel Clark Foundation. A preliminary account of this work has been published (4).

2 To whom requests for reprints should be addressed, at Department of Pharmacology and Experimental Therapeutics, The Johns Hopkins University School of Medicine, 725 N. Wolfe Street, Baltimore, Md. 21205.

Received 4/26/78. Accepted 8/23/78.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Mu, J. Zhang, S. Zhang, H.-H. Zhou, D. Toma, S. Ren, L. Huang, M. Yaramus, A. Baum, R. Venkataramanan, et al.
Traditional Chinese Medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) Activate Pregnane X Receptor and Increase Warfarin Clearance in Rats
J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1369 - 1377.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Talalay
A Fascination with Enzymes: The Journey Not the Arrival Matters
J. Biol. Chem., August 12, 2005; 280(32): 28829 - 28847.
[Full Text] [PDF]


Home page
Cancer Res.Home page
K. Iida, K. Itoh, Y. Kumagai, R. Oyasu, K. Hattori, K. Kawai, T. Shimazui, H. Akaza, and M. Yamamoto
Nrf2 Is Essential for the Chemopreventive Efficacy of Oltipraz against Urinary Bladder Carcinogenesis
Cancer Res., September 15, 2004; 64(18): 6424 - 6431.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. V. Nesterova and Y. S. Cho-Chung
Antisense Protein Kinase A RI{alpha} Inhibits 7,12-Dimethylbenz(a)anthracene-Induction of Mammary Cancer: Blockade at the Initial Phase of Carcinogenesis
Clin. Cancer Res., July 1, 2004; 10(13): 4568 - 4577.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. J. Ansell, C. Espinosa-Nicholas, E. M. Curran, B. M. Judy, B. J. Philips, M. Hannink, and D. B. Lubahn
In Vitro and in Vivo Regulation of Antioxidant Response Element-Dependent Gene Expression by Estrogens
Endocrinology, January 1, 2004; 145(1): 311 - 317.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. H. Conney
Enzyme Induction and Dietary Chemicals as Approaches to Cancer Chemoprevention: The Seventh DeWitt S. Goodman Lecture
Cancer Res., November 1, 2003; 63(21): 7005 - 7031.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Yanaida, H. Kohno, K. Yoshida, Y. Hirose, Y. Yamada, H. Mori, and T. Tanaka
Dietary silymarin suppresses 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats
Carcinogenesis, May 1, 2002; 23(5): 787 - 794.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Satoh, K. Itoh, M. Yamamoto, M. Tanaka, M. Hayakari, K. Ookawa, T. Yamazaki, T. Sato, S. Tsuchida, and I. Hatayama
Nrf2 transactivator-independent GSTP1-1 expression in `GSTP1-1 positive' single cells inducible in female mouse liver by DEN: a preneoplastic character of possible initiated cells
Carcinogenesis, March 1, 2002; 23(3): 457 - 462.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. M. Croce
How can we prevent cancer?
PNAS, September 25, 2001; 98(20): 10986 - 10988.
[Full Text] [PDF]


Home page
Toxicol SciHome page
K. L. Henson, G. Stauffer, and E. P. Gallagher
Induction of Glutathione S-transferase Activity and Protein Expression in Brown Bullhead (Ameiurus nebulosus) Liver by Ethoxyquin
Toxicol. Sci., July 1, 2001; 62(1): 54 - 60.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. R. Wolf
Chemoprevention: Increased potential to bear fruit
PNAS, March 13, 2001; 98(6): 2941 - 2943.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. T. Dinkova-Kostova, M. A. Massiah, R. E. Bozak, R. J. Hicks, and P. Talalay
From the Cover: Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups
PNAS, March 13, 2001; 98(6): 3404 - 3409.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Ramos-Gomez, M.-K. Kwak, P. M. Dolan, K. Itoh, M. Yamamoto, P. Talalay, and T. W. Kensler
From the Cover: Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice
PNAS, March 13, 2001; 98(6): 3410 - 3415.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Tanaka, H. Kohno, R. Shimada, S. Kagami, F. Yamaguchi, S. Kataoka, T. Ariga, A. Murakami, K. Koshimizu, and H. Ohigashi
Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats
Carcinogenesis, June 1, 2000; 21(6): 1183 - 1189.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Ishii, K. Itoh, J. Akasaka, T. Yanagawa, S. Takahashi, H. Yoshida, S. Bannai, and M. Yamamoto
Induction of murine intestinal and hepatic peroxiredoxin MSP23 by dietary butylated hydroxyanisole
Carcinogenesis, May 1, 2000; 21(5): 1013 - 1016.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
F. P. Guengerich
Metabolism of chemical carcinogens
Carcinogenesis, March 1, 2000; 21(3): 345 - 351.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Yu, W. Lei, S. Mandlekar, M. J. Weber, C. J. Der, J. Wu, and A.-N. T. Kong
Role of a Mitogen-activated Protein Kinase Pathway in the Induction of Phase II Detoxifying Enzymes by Chemicals
J. Biol. Chem., September 24, 1999; 274(39): 27545 - 27552.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Tanaka, K. Kawabata, M. Kakumoto, H. Makita, J. Ushida, S. Honjo, A. Hara, H. Tsuda, and H. Mori
Modifying effects of a flavonoid morin on azoxymethane-induced large bowel tumorigenesis in rats
Carcinogenesis, August 1, 1999; 20(8): 1477 - 1484.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J.-S. Wang, X. Shen, X. He, Y.-R. Zhu, B.-C. Zhang, J.-B. Wang, G.-S. Qian, S.-Y. Kuang, A. Zarba, P. A. Egner, et al.
Protective Alterations in Phase 1 and 2 Metabolism of Aflatoxin B1 by Oltipraz in Residents of Qidong, People's Republic of China
J Natl Cancer Inst, February 17, 1999; 91(4): 347 - 354.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Yu, T.-H. Tan, and A.-N. T. Kong
Butylated Hydroxyanisole and Its Metabolite tert-Butylhydroquinone Differentially Regulate Mitogen-activated Protein Kinases. THE ROLE OF OXIDATIVE STRESS IN THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASES BY PHENOLIC ANTIOXIDANTS
J. Biol. Chem., November 14, 1997; 272(46): 28962 - 28970.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Hu, S. K. Srivastava, H. Xia, Y. C. Awasthi, and S. V. Singh
An Alpha Class Mouse Glutathione S-Transferase with Exceptional Catalytic Efficiency in the Conjugation of Glutathione with 7beta ,8alpha -Dihydroxy-9alpha ,10alpha -oxy-7,8,9,10-tetrahydrobenzo(a)pyrene
J. Biol. Chem., December 20, 1996; 271(51): 32684 - 32688.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. E. McHugh, W. M. Atkins, J. K. Racha, K. L. Kunze, and D. L. Eaton
Binding of the Aflatoxin-Glutathione Conjugate to Mouse Glutathione S-Transferase A3-3 Is Saturated at Only One Ligand per Dimer
J. Biol. Chem., November 1, 1996; 271(44): 27470 - 27474.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
A Meister
Selective modification of glutathione metabolism
Science, April 29, 1983; 220(4596): 472 - 477.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1978 by the American Association for Cancer Research.